Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Impact of pharmacist intervention on the utilization of sitagliptin use in the ckd
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: LEE, Chi-Hui (China Taiwan)
- Co-author(s): Chi-Hui Lee
BackgroundSitagliptin is the first DPP-IV inhibitor and studies have demonstrated that appropriate reductions dose in chronic kidney disease (CKD) patients.
PurposeThis study was to evaluate the impacts of pharmacist intervention on sitagliptin utilization in chronic kidney disease .
MethodsThis study was divided into three periods of repetitive.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019